These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 25121994)

  • 41. Effect size of symptom status in withdrawal of typical antipsychotics and subsequent clozapine treatment in patients with treatment-resistant schizophrenia.
    Pickar D; Bartko JJ
    Am J Psychiatry; 2003 Jun; 160(6):1133-8. PubMed ID: 12777272
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clozapine Combination and Augmentation Strategies in Patients With Schizophrenia -Recommendations From an International Expert Survey Among the Treatment Response and Resistance in Psychosis (TRRIP) Working Group.
    Wagner E; Kane JM; Correll CU; Howes O; Siskind D; Honer WG; Lee J; Falkai P; Schneider-Axmann T; Hasan A;
    Schizophr Bull; 2020 Dec; 46(6):1459-1470. PubMed ID: 32421188
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of sertindole on cognition in clozapine-treated schizophrenia patients.
    Nielsen RE; Levander S; Thode D; Nielsen J
    Acta Psychiatr Scand; 2012 Jul; 126(1):31-9. PubMed ID: 22356584
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Augmentation strategies in partial responder and/or treatment-resistant schizophrenia patients treated with clozapine.
    Muscatello MR; Bruno A; De Fazio P; Segura-Garcia C; Pandolfo G; Zoccali R
    Expert Opin Pharmacother; 2014 Nov; 15(16):2329-45. PubMed ID: 25284216
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risperidone versus clozapine in treatment-resistant chronic schizophrenia: a randomized double-blind study. The Risperidone Study Group.
    Bondolfi G; Dufour H; Patris M; May JP; Billeter U; Eap CB; Baumann P
    Am J Psychiatry; 1998 Apr; 155(4):499-504. PubMed ID: 9545995
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Does the addition of a second antipsychotic drug improve clozapine treatment?
    Barbui C; Signoretti A; Mulè S; Boso M; Cipriani A
    Schizophr Bull; 2009 Mar; 35(2):458-68. PubMed ID: 18436527
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antipsychotic polypharmacy and augmentation strategies prior to clozapine initiation: a historical cohort study of 310 adults with treatment-resistant schizophrenic disorders.
    Thompson JV; Clark JM; Legge SE; Kadra G; Downs J; Walters JT; Hamshere ML; Hayes RD; Taylor D; MacCabe JH
    J Psychopharmacol; 2016 May; 30(5):436-43. PubMed ID: 26905920
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adjunct mirtazapine for negative symptoms of schizophrenia.
    Phan SV; Kreys TJ
    Pharmacotherapy; 2011 Oct; 31(10):1017-30. PubMed ID: 21950644
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of topiramate augmentation in chronic schizophrenia: a placebo-controlled trial.
    Behdani F; Hebrani P; Rezaei Ardani A; Rafee E
    Arch Iran Med; 2011 Jul; 14(4):270-5. PubMed ID: 21726104
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Amisulpride augmentation of clozapine: an open non-randomized study in patients with schizophrenia partially responsive to clozapine.
    Munro J; Matthiasson P; Osborne S; Travis M; Purcell S; Cobb AM; Launer M; Beer MD; Kerwin R
    Acta Psychiatr Scand; 2004 Oct; 110(4):292-8. PubMed ID: 15352931
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combination of ziprasidone and clozapine in treatment-resistant schizophrenia.
    Zink M; Mase E; Dressing H
    Hum Psychopharmacol; 2004 Jun; 19(4):271-3. PubMed ID: 15181656
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Augmentation strategies in clozapine-resistant schizophrenia.
    Remington G; Saha A; Chong SA; Shammi C
    CNS Drugs; 2005; 19(10):843-72. PubMed ID: 16185094
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia: a 12-month, randomized, naturalistic trial.
    Cipriani A; Accordini S; Nosè M; Purgato M; Girlanda F; Tansella M; Barbui C
    J Clin Psychopharmacol; 2013 Aug; 33(4):533-7. PubMed ID: 23775051
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy and safety of extract of Ginkgo biloba as an adjunct therapy in chronic schizophrenia: A systematic review of randomized, double-blind, placebo-controlled studies with meta-analysis.
    Chen X; Hong Y; Zheng P
    Psychiatry Res; 2015 Jul; 228(1):121-7. PubMed ID: 25980333
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Add-on mirtazapine enhances effects on cognition in schizophrenic patients under stabilized treatment with clozapine.
    Delle Chiaie R; Salviati M; Fiorentini S; Biondi M
    Exp Clin Psychopharmacol; 2007 Dec; 15(6):563-8. PubMed ID: 18179309
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Favourable results in treatment-resistant schizophrenic patients under combination of aripiprazole with clozapine.
    Mossaheb N; Spindelegger C; Asenbaum S; Fischer P; Barnas C
    World J Biol Psychiatry; 2010 Mar; 11(2 Pt 2):502-5. PubMed ID: 20218805
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sulpiride augmentation in people with schizophrenia partially responsive to clozapine. A double-blind, placebo-controlled study.
    Shiloh R; Zemishlany Z; Aizenberg D; Radwan M; Schwartz B; Dorfman-Etrog P; Modai I; Khaikin M; Weizman A
    Br J Psychiatry; 1997 Dec; 171():569-73. PubMed ID: 9519099
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Case report: Pharmacokinetic interaction between clozapine and mirtazapine.
    Lo Presti C; Laguin S; Bambina E; Arlotto E; Aghazarian V; Guise-Honore S
    Encephale; 2019 Sep; 45(4):363-364. PubMed ID: 30879778
    [No Abstract]   [Full Text] [Related]  

  • 59. A double-blind comparative study of clozapine and risperidone in the management of severe chronic schizophrenia.
    Azorin JM; Spiegel R; Remington G; Vanelle JM; Péré JJ; Giguere M; Bourdeix I
    Am J Psychiatry; 2001 Aug; 158(8):1305-13. PubMed ID: 11481167
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Augmentation with sulpiride for a schizophrenic patient partially responsive to clozapine.
    Stubbs JH; Haw CM; Staley CJ; Mountjoy CQ
    Acta Psychiatr Scand; 2000 Nov; 102(5):390-3; discussion 393-4. PubMed ID: 11098812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.